These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9236484)

  • 1. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.
    Vollmer-Conna U; Hickie I; Hadzi-Pavlovic D; Tymms K; Wakefield D; Dwyer J; Lloyd A
    Am J Med; 1997 Jul; 103(1):38-43. PubMed ID: 9236484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.
    Lloyd A; Hickie I; Wakefield D; Boughton C; Dwyer J
    Am J Med; 1990 Nov; 89(5):561-8. PubMed ID: 2146875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.
    Lloyd AR; Hickie I; Brockman A; Hickie C; Wilson A; Dwyer J; Wakefield D
    Am J Med; 1993 Feb; 94(2):197-203. PubMed ID: 8430715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome.
    Peterson PK; Shepard J; Macres M; Schenck C; Crosson J; Rechtman D; Lurie N
    Am J Med; 1990 Nov; 89(5):554-60. PubMed ID: 2239975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.
    Roerink ME; Knoop H; Bredie SJ; Heijnen M; Joosten LA; Netea MG; Dinarello CA; van der Meer JW
    Trials; 2015 Oct; 16():439. PubMed ID: 26438161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD003200. PubMed ID: 27995604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003200. PubMed ID: 25674924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.
    Strayer DR; Carter WA; Brodsky I; Cheney P; Peterson D; Salvato P; Thompson C; Loveless M; Shapiro DE; Elsasser W
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S88-95. PubMed ID: 8148460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome.
    Hickie I; Lloyd A; Wakefield D
    Aust N Z J Psychiatry; 1992 Jun; 26(2):249-56. PubMed ID: 1642616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study.
    Young JL
    Psychiatry Res; 2013 May; 207(1-2):127-33. PubMed ID: 23062791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
    Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G
    Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.
    Montoya JG; Kogelnik AM; Bhangoo M; Lunn MR; Flamand L; Merrihew LE; Watt T; Kubo JT; Paik J; Desai M
    J Med Virol; 2013 Dec; 85(12):2101-9. PubMed ID: 23959519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.
    McDermott C; Richards SC; Thomas PW; Montgomery J; Lewith G
    QJM; 2006 Jul; 99(7):461-8. PubMed ID: 16809351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term methylphenidate intake in chronic fatigue syndrome.
    Blockmans D; Persoons P
    Acta Clin Belg; 2016 Dec; 71(6):407-414. PubMed ID: 27351244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
    Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J
    Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial.
    Blacker CV; Greenwood DT; Wesnes KA; Wilson R; Woodward C; Howe I; Ali T
    JAMA; 2004 Sep; 292(10):1195-204. PubMed ID: 15353532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
    Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study.
    Blockmans D; Persoons P; Van Houdenhove B; Lejeune M; Bobbaers H
    Am J Med; 2003 Jun; 114(9):736-41. PubMed ID: 12829200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.